Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across multiple tumor types...
The Annual Meeting is the foremost educational and scientific event for gynecologic oncologistsStenoparib has shown clinical benefit in...
SAN DIEGO and TORONTO, March 17, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:...
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry...
EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test AccuracyMISSISSAUGA, Ontario and MELBOURNE, Australia, March 17, 2025 (GLOBE...
BENGALURU, India , March 17, 2025 /PRNewswire/ -- 4baseCare, a leader in precision oncology, has achieved a major milestone with CAP...
- The late-breaking oral presentation at SGO 2025 highlights consistent response rates observed in patients across all levels of FRα...
Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients...
Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically relevant...
Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency (“RF”)...
Strategic agreement will standardize clinical pathways through ACROPath® BOONE, N.C., March 13, 2025 /PRNewswire/ -- Fuse Oncology, an oncology healthcare software...
BMRT's Revolutionary Technology Can Instantly Detect Infected Poultry, Preventing the Unnecessary Slaughter of Healthy Animals STUART, Fla., March 13, 2025 /PRNewswire/...
The partnership enables Teladoc Health's employer clients and members more streamlined and fully integrated access to Carrum's value-based Centers of...
New clinical research from the Helix Research NetworkTM showcases how genomics improves risk identification, care adherence and precision medicine implementation...
CAMBRIDGE, Mass., March 13, 2025 /PRNewswire/ -- Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today...
WASHINGTON, March 13, 2025 /PRNewswire/ -- The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event,...
Proceeds from today’s financing, when added to existing cash, fund operations through Q1 2026 The Company is planning to announce...
In-Motion Webinar: Bionano will host a webinar featuring the study’s lead author, Dr. Guilin Tang, who will discuss the study...
Aims to raise vital funding for the iStopMM Project and Other IMF Research InitiativesSTUDIO CITY, Calif., March 13, 2025 (GLOBE...
Kane to work with the University of Miami to study DispersinB® Acne Cleanser in mild to moderate Acne VulgarisWINNIPEG, Manitoba,...